PD-L1 expression by IHC in BC is low (around 10–30%) compared with other tumors, such as lung cancer, and varies with stage and the molecular subtype, being the highest expression in triple-negative breast cancer (TNBC), ranging from 30 to 60% [7,8]. This evidence concerns the gene CD274 and breast cancer.